Viral Infections and Antiviral Therapies provides comprehensive coverage of viral infections and their transmission. Coverage includes antiviral agents, therapeutics, their mechanisms and treatment strategies. The book is organized into four sections, including an introduction to antiviral therapies, viral infections and their transmission, antiviral agents and therapeutics, and a market overview and future developments. The chapters in each section of the book discuss various key topics that are contributed to by an international group of leading experts.
Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.
Table of Contents
Section I: Introduction 1. Introduction to antiviral therapy
Section II: Viral infections and transmission 2. Emerging viral diseases 3. Evolution and transmission of viruses 4. Mode of viral infections and transmissions 5. Transmission and Intervention Dynamics of SARS-CoV-2 6. Sexually transmitted viral infections 7. Testing of viral infections 8. Electron microscopic methods for virus diagnosis
Section III: Antiviral agents and therapeutics 9. Virotherapy 10. Challenges in designing antiviral agents 11. Anti-influenza agents 12. Anti-herpes virus agents 13. Antiretroviral Therapies 14. Rotavirus and anti-rotaviral agents: Trends and advances 15. Current therapeutic strategies and novel antiviral compounds for the treatment of non-polio enteroviruses 16. Antiviral agents against flaviviruses 17. Pathophysiology of HIV and strategies to eliminate AIDS as a public health threat 18. Herbal drugs to combat viruses 19. Strategies for delivery of antiviral agents 20. Nanovesicles for delivery of antiviral agents 21. Antiviral biomaterials 22. Antiviral biomolecules from marine inhabitantsBalasubramanian 23. Plant polysaccharides as antiviral agents 24. Antiviral peptides against dengue virus 25. mRNA vaccines for COVID-19 26. Immunotherapy as an emerging and promising tool against viral infections 27. Role of nutraceuticals as immunomodulators to combat viruses
Section IV: Others 28. In vitro and in vivo approaches for evaluating antiviral efficacy 29. Clinical trials and regulatory considerations of antiviral agents 30. Future perspectives of antiviral therapy
Authors
Amal Kumar Dhara Department of Pharmacy, Contai Polytechnic, Government of West Bengal, Contai, Purba Medinipur, West Bengal, India. Dr. Amal Kumar Dhara (MPharm, PhD) has over 20 years of teaching and research experience in the fields of Pharmacology and Toxicology, especially in the areas of neuropharmacology and anti-inflammatory, antiulcer, and free radical scavenging activities of indigenous Indian plants. He earned his PhD in Pharmaceutical Sciences from Jadavpur University, Kolkata, West Bengal, India. Currently, Dr. Dhara works as a Lecturer in Pharmacy (Associate Professor) at Contai Polytechnic, Purba Medinipur, West Bengal, India. Amit Kumar Nayak Department of Pharmaceutics, School of Pharmaceutical Sciences, Siksha 'O' Anusandhan (Deemed to be University), Bhubaneswar, Odisha, India.Dr. Amit Kumar Nayak (MPharm, PhD) is working as a professor, at the Department of Pharmaceutics, School of Pharmaceutical Sciences, Siksha 'O' Anusandhan (Deemed to be University), Odisha, India. He has earned his PhD from IFTM University, Moradabad, Uttar Pradesh, India. He has over 14 years of research experiences in the field of pharmaceutics, especially in the development and characterization of novel biopolymeric and nanostructured drug delivery systems. Till date, he has authored more than 138 research and review publications in various high-impact peer-reviewed journals and 135 book chapters. He has edited/authored 23 international books to his credit. Dr. Nayak has presented his research work at several conferences. He has received University Foundation Day Research Award, 2019 and 2022 by Biju Patnaik University of Technology, Odisha. Dr. Nayak is a life member of the Association of Pharmaceutical Teachers of India (APTI) and a registered pharmacist.
